Overall rank by patents
#38,187
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).
The verdict
According to USPTO PatentsView, Verinetics ranks #38,187 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R38187 · US Corporation #38,187 · 7 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Verato, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Verinetics · this assignee
43 score
3D Lighting… · lowest
7 score
What this shows Verinetics's Innovation Score is 43.2/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Verinetics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 42.9% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). By volume, Verinetics sits between Verato, Inc. and Versus LLC.
Verinetics, Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Verato, Inc.
7 patents
Verdigris Technologies, Inc.
7 patents
Vergence Automation, Inc.
7 patents
VeriPhase, Inc.
7 patents
Verna IP Holdings, LLC
7 patents
Versa Products Inc.
7 patents
Versi LLC
7 patents
Versus LLC
7 patents
Verinetics, Inc.
7 patents
What this shows Verinetics holds 7 patents at rank #38,197, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #38,197 in granted patent volume.
Other assignees with the most granted patents in Verinetics's primary technology class.
Verinetics's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 14.3% |
| 2021 | 1 | 14.3% |
| 2022 | 1 | 14.3% |
| 2023 | 1 | 14.3% |
| 2025partial year | 3 | 42.9% |
Top 10 of 10 technology areas
Overall rank by patents
#38,187
of 49,997 tracked assignees
43.2 out of 100
What to do with this data
Verinetics, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.